除了炎症之外:警示素作为肺纤维化症的关键驱动因素
Tommaso Pianigiani1, Akter Dilroba1, Claudia Gambini1
1Respiratory Diseases and Lung Transplantation Unit, Department of Medical and Surgical Sciences and Neurosciences, University of Siena, Siena, Italy.
ERJ open research
|March 11, 2026
概括
皮质警示蛋白,如胸膜 stromal 淋巴蛋白,IL-25和IL-33是肺纤维化的主要驱动因素. 了解它们在免疫反应中的作用可能会导致肺纤维化治疗的新向疗法.
科学领域:
- 肺部医学 肺部医学
- 免疫学 免疫学 免疫学
- 细胞生物学 细胞生物学
背景情况:
- 肺纤维化涉及过多的纤维组织沉积在肺部.
- 皮质警示素与异常性肺纤维化和结缔组织疾病相关的间歇性肺病的病原发生有关.
研究的目的:
- 审查在肺纤维化中表皮性警示素的作用.
- 探索它们作为损伤相关分子模式的功能及其对免疫细胞吸引力的影响.
- 了解它们对纤维化2型免疫网络的贡献.
主要方法:
- 现有文献的叙述性审查.
- 分析了胸膜层淋巴质蛋白,IL-25和IL-33的功能.
- 检查它们在免疫细胞相互作用和上皮细胞-介质细胞过渡中的作用.
主要成果:
- 皮质警示素作为损伤相关的分子模式,吸引免疫细胞.
- 它们调节纤维细胞-巨细胞相互作用,影响巨细胞两极分化和上皮细胞-介质细胞过渡.
- 这些警示素对于激活2型免疫网络至关重要,这在肺纤维化中很重要.
结论:
- 皮质警示素在对肺纤维化免疫反应中起着重要作用.
- 准这些警示素可能为肺纤维化提供新的治疗策略.
相关概念视频
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
5.0K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
5.0K
Drugs Used in Lower Respiratory Disorders: Overview
1.4K
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
1.4K
Asthma-II: Pathophysiology and Classification
4.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.7K


